Author

Haggai Kaspi

Observed name: H. Kaspi

Observed institutions: Mayo Clinic, Harvard University, University of Massachusetts Chan Medical School, Massachusetts General Hospital, Weizmann Institute of Science

ORCID: 0009-0001-3710-700X

Observed ORCID: 0009-0001-3710-700X

OpenAlex ID: A5032650964

NurOwn, phase 2, randomized, clinical trial in patients with ALS

2019 · James D. Berry, Merit E. Cudkowicz, et al. · Neurology · 163

MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

2021 · Haggai Kaspi, Jonathan Semo, et al. · Stem Cell Research & Therapy · 68

MiR-375 Promotes Redifferentiation of Adult Human β Cells Expanded In Vitro

2015 · Gili Nathan, Sharon Kredo-Russo, et al. · PLoS ONE · 67

Could microRNAs contribute to the maintenance of β cell identity?

2014 · Haggai Kaspi, Ronit Pasvolsky, et al. · Trends in Endocrinology and Metabolism · 44

Brief report: miR-290–295 regulate embryonic stem cell differentiation propensities by repressing pax6

2013 · Haggai Kaspi, Elik Chapnik, et al. · Stem Cells · 32

miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors

2017 · Yael Gothelf, Haggai Kaspi, et al. · Stem Cell Research & Therapy · 27

Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

2024 · Stacy R. Lindborg, Namita A. Goyal, et al. · Muscle & Nerve · 6

Effects of MSC-NTF cells on T and B regulatory cell function in ALS

2020 · Ralph Kern, Revital Aricha, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 3

MSC-NTF Cell Immunomodulation: Effects on T and B Regulatory Cells (790)

2020 · Revital Aricha, Natalie Abramov, et al. · Neurology · 1

MODULATION OF CSF miRNAs IN ALS PHASE 2 STUDY PARTICIPANTS TREATED WITH MSC-NTF CELLS (NUROWN®) (S25.005)

2018 · Revital Aricha, Haggai Kaspi, et al. · Neurology · 1

Beneficial effects of small extracellular vesicles derived from MSC-NTF (NurOwn®) cells on lung inflammation and fibrosis

2026 · Haggai Kaspi, Chen Dekel, et al. · Stem Cell Research & Therapy

Small Extracellular Vesicles From MSC-NTF Cells Induce Significant Improvement in Inflammatory Lung Disease Models

2023 · H. Kaspi, C. Dekel, et al.

Mesenchymal Stem/Stromal Cells: CONSIDERATION OF COMPARTMENT EFFECT ON BIOMARKER ANALYSIS: LESSONS LEARNED FROM BRAINSTORM’S PHASE III CLINICAL TRIAL EVALUATING MSC-NTF CELL THERAPY IN ALS

2023 · N. Blondheim-Shraga, H. Kaspi, et al. · Cytotherapy

Exosomes/EVs: MSC-NTF DERIVED SMALL EXTRACELLULAR VESICLES DISPLAY SUPERIOUR MACROPHAGE IMMUNOMODULATION COMPARED WITH VESICLES DERIVED FROM NAIVE MSC

2022 · C. Dekel, H. Kaspi, et al. · Cytotherapy

Molecular mechanisms underlying MSC-NTF (nurown®) exosome benefits in a mouse LPS-induced ards model

2021 · H. Kaspi, J. Semo, et al. · Cytotherapy

Molecular Characterization of VEGF Secretion by MSC-NTF Cells (NurOwn®): Therapeutic Implications in ALS (P5.2-081)

2019 · Haggai Kaspi, Revital Aricha, et al. · Neurology

Works count: 16

Citation count: 412

H-index: 6

I10-index: 6